Sensorion

Developing life-transforming therapies for patients with inner ear disorders involving vertigo and hearing loss.

Launch date

Jan 2009

Employees

Market cap

Net debt

-

Enterprise valuation

$194m (Public information from May 2024)

Company register number 512757725

Montpellier Occitanie (HQ)

https://www.sensorion.com/

https://twitter.com/sensorionpharma https://www.linkedin.com/company/sensorionph

View job openings

No columns specified